PDAP1 and breast cancer: Previos studies showed that PDAP1 is overexpressed and/or involved in the progression of several cancers including gastric cancer, rectal carcinoma, glioma, and colorectal cancer.[28] We selected PDAP1 since it is significantly highly expressed in breast cancer patients, particularly in TNBC (Figure 4A).